Global Ex Vivo Organ Perfusion Market Growth (Status and Outlook) 2026-2032

July 2026 | 105 pages | ID: GEAFE2F7D6EDEN
LP Information

Abstracts

The global Ex Vivo Organ Perfusion market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Ex vivo organ perfusion is a technique used in transplantation and research to preserve and evaluate organs outside of the body before transplantation. During ex vivo perfusion, the organ is connected to a perfusion system that delivers oxygenated blood or a specialized preservation solution to maintain the organ's viability and function. This process allows for the assessment and optimization of organ function, as well as the potential for organ repair or treatment prior to transplantation. Ex vivo organ perfusion offers several advantages over traditional static cold storage, including the ability to assess organ viability, reduce ischemic injury, and potentially expand the donor pool by allowing for the use of marginal or extended criteria organs. Additionally, ex vivo perfusion enables researchers to study organ physiology, test new therapies, and improve transplantation outcomes.

This report presents a comprehensive overview, market shares, and growth opportunities of Ex Vivo Organ Perfusion market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Heart Perfusion
• Liver Perfusion
• Kidney Perfusion
• Lung Perfusion

Segmentation by Application:

• Organ Transplant Specialist Hospitals
• Organ Banks
• Pharmaceutical Research Organizations

This report also splits the market by region:

• United States
• China%li%
• Europe
• Other regions
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• TransMedics
• Lung Bioengineering
• OrganOx
• XVIVO
• TNO
• UHN
• SCREEN
• Bridge to Life
• Organ Recovery Systems
• Institut Georges Lopez
• Ebers
• Penn Medicine
• Johns Hopkins Medicine

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Ex Vivo Organ Perfusion Market Size (2021-2032)
  2.1.2 Ex Vivo Organ Perfusion Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Ex Vivo Organ Perfusion by Country/Region (2021, 2025 & 2032)
2.2 Ex Vivo Organ Perfusion Segment by Type
  2.2.1 Heart Perfusion
  2.2.2 Liver Perfusion
  2.2.3 Kidney Perfusion
  2.2.4 Lung Perfusion
  2.2.5 Ex Vivo Organ Perfusion Market Size by Type
    2.2.5.1 Ex Vivo Organ Perfusion Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.5.2 Global Ex Vivo Organ Perfusion Market Size Market Share by Type (2021-2026)
2.3 Ex Vivo Organ Perfusion Segment by Application
  2.3.1 Organ Transplant Specialist Hospitals
  2.3.2 Organ Banks
  2.3.3 Pharmaceutical Research Organizations
  2.3.4 Ex Vivo Organ Perfusion Market Size by Application
    2.3.4.1 Ex Vivo Organ Perfusion Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Ex Vivo Organ Perfusion Market Size Market Share by Application (2021-2026)

3 EX VIVO ORGAN PERFUSION MARKET SIZE BY PLAYER

3.1 Ex Vivo Organ Perfusion Market Size Market Share by Player
  3.1.1 Global Ex Vivo Organ Perfusion Revenue by Player (2021-2026)
  3.1.2 Global Ex Vivo Organ Perfusion Revenue Market Share by Player (2021-2026)
3.2 Global Ex Vivo Organ Perfusion Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 EX VIVO ORGAN PERFUSION BY REGION

4.1 Ex Vivo Organ Perfusion Market Size by Region (2021-2026)
4.2 Global Ex Vivo Organ Perfusion Annual Revenue by Country/Region (2021-2026)
4.3 Americas Ex Vivo Organ Perfusion Market Size Growth (2021-2026)
4.4 APAC Ex Vivo Organ Perfusion Market Size Growth (2021-2026)
4.5 Europe Ex Vivo Organ Perfusion Market Size Growth (2021-2026)
4.6 Middle East & Africa Ex Vivo Organ Perfusion Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Ex Vivo Organ Perfusion Market Size by Country (2021-2026)
5.2 Americas Ex Vivo Organ Perfusion Market Size by Type (2021-2026)
5.3 Americas Ex Vivo Organ Perfusion Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Ex Vivo Organ Perfusion Market Size by Region (2021-2026)
6.2 APAC Ex Vivo Organ Perfusion Market Size by Type (2021-2026)
6.3 APAC Ex Vivo Organ Perfusion Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Ex Vivo Organ Perfusion Market Size by Country (2021-2026)
7.2 Europe Ex Vivo Organ Perfusion Market Size by Type (2021-2026)
7.3 Europe Ex Vivo Organ Perfusion Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Ex Vivo Organ Perfusion by Region (2021-2026)
8.2 Middle East & Africa Ex Vivo Organ Perfusion Market Size by Type (2021-2026)
8.3 Middle East & Africa Ex Vivo Organ Perfusion Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL EX VIVO ORGAN PERFUSION MARKET FORECAST

10.1 Global Ex Vivo Organ Perfusion Forecast by Region (2027-2032)
  10.1.1 Global Ex Vivo Organ Perfusion Forecast by Region (2027-2032)
  10.1.2 Americas Ex Vivo Organ Perfusion Forecast
  10.1.3 APAC Ex Vivo Organ Perfusion Forecast
  10.1.4 Europe Ex Vivo Organ Perfusion Forecast
  10.1.5 Middle East & Africa Ex Vivo Organ Perfusion Forecast
10.2 Americas Ex Vivo Organ Perfusion Forecast by Country (2027-2032)
  10.2.1 United States Market Ex Vivo Organ Perfusion Forecast
  10.2.2 Canada Market Ex Vivo Organ Perfusion Forecast
  10.2.3 Mexico Market Ex Vivo Organ Perfusion Forecast
  10.2.4 Brazil Market Ex Vivo Organ Perfusion Forecast
10.3 APAC Ex Vivo Organ Perfusion Forecast by Region (2027-2032)
  10.3.1 China Ex Vivo Organ Perfusion Market Forecast
  10.3.2 Japan Market Ex Vivo Organ Perfusion Forecast
  10.3.3 Korea Market Ex Vivo Organ Perfusion Forecast
  10.3.4 Southeast Asia Market Ex Vivo Organ Perfusion Forecast
  10.3.5 India Market Ex Vivo Organ Perfusion Forecast
  10.3.6 Australia Market Ex Vivo Organ Perfusion Forecast
10.4 Europe Ex Vivo Organ Perfusion Forecast by Country (2027-2032)
  10.4.1 Germany Market Ex Vivo Organ Perfusion Forecast
  10.4.2 France Market Ex Vivo Organ Perfusion Forecast
  10.4.3 UK Market Ex Vivo Organ Perfusion Forecast
  10.4.4 Italy Market Ex Vivo Organ Perfusion Forecast
  10.4.5 Russia Market Ex Vivo Organ Perfusion Forecast
10.5 Middle East & Africa Ex Vivo Organ Perfusion Forecast by Region (2027-2032)
  10.5.1 Egypt Market Ex Vivo Organ Perfusion Forecast
  10.5.2 South Africa Market Ex Vivo Organ Perfusion Forecast
  10.5.3 Israel Market Ex Vivo Organ Perfusion Forecast
  10.5.4 Turkey Market Ex Vivo Organ Perfusion Forecast
10.6 Global Ex Vivo Organ Perfusion Forecast by Type (2027-2032)
10.7 Global Ex Vivo Organ Perfusion Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Ex Vivo Organ Perfusion Forecast

11 KEY PLAYERS ANALYSIS

11.1 TransMedics
  11.1.1 TransMedics Company Information
  11.1.2 TransMedics Ex Vivo Organ Perfusion Product Offered
  11.1.3 TransMedics Ex Vivo Organ Perfusion Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 TransMedics Main Business Overview
  11.1.5 TransMedics Latest Developments
11.2 Lung Bioengineering
  11.2.1 Lung Bioengineering Company Information
  11.2.2 Lung Bioengineering Ex Vivo Organ Perfusion Product Offered
  11.2.3 Lung Bioengineering Ex Vivo Organ Perfusion Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Lung Bioengineering Main Business Overview
  11.2.5 Lung Bioengineering Latest Developments
11.3 OrganOx
  11.3.1 OrganOx Company Information
  11.3.2 OrganOx Ex Vivo Organ Perfusion Product Offered
  11.3.3 OrganOx Ex Vivo Organ Perfusion Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 OrganOx Main Business Overview
  11.3.5 OrganOx Latest Developments
11.4 XVIVO
  11.4.1 XVIVO Company Information
  11.4.2 XVIVO Ex Vivo Organ Perfusion Product Offered
  11.4.3 XVIVO Ex Vivo Organ Perfusion Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 XVIVO Main Business Overview
  11.4.5 XVIVO Latest Developments
11.5 TNO
  11.5.1 TNO Company Information
  11.5.2 TNO Ex Vivo Organ Perfusion Product Offered
  11.5.3 TNO Ex Vivo Organ Perfusion Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 TNO Main Business Overview
  11.5.5 TNO Latest Developments
11.6 UHN
  11.6.1 UHN Company Information
  11.6.2 UHN Ex Vivo Organ Perfusion Product Offered
  11.6.3 UHN Ex Vivo Organ Perfusion Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 UHN Main Business Overview
  11.6.5 UHN Latest Developments
11.7 SCREEN
  11.7.1 SCREEN Company Information
  11.7.2 SCREEN Ex Vivo Organ Perfusion Product Offered
  11.7.3 SCREEN Ex Vivo Organ Perfusion Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 SCREEN Main Business Overview
  11.7.5 SCREEN Latest Developments
11.8 Bridge to Life
  11.8.1 Bridge to Life Company Information
  11.8.2 Bridge to Life Ex Vivo Organ Perfusion Product Offered
  11.8.3 Bridge to Life Ex Vivo Organ Perfusion Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Bridge to Life Main Business Overview
  11.8.5 Bridge to Life Latest Developments
11.9 Organ Recovery Systems
  11.9.1 Organ Recovery Systems Company Information
  11.9.2 Organ Recovery Systems Ex Vivo Organ Perfusion Product Offered
  11.9.3 Organ Recovery Systems Ex Vivo Organ Perfusion Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Organ Recovery Systems Main Business Overview
  11.9.5 Organ Recovery Systems Latest Developments
11.10 Institut Georges Lopez
  11.10.1 Institut Georges Lopez Company Information
  11.10.2 Institut Georges Lopez Ex Vivo Organ Perfusion Product Offered
  11.10.3 Institut Georges Lopez Ex Vivo Organ Perfusion Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Institut Georges Lopez Main Business Overview
  11.10.5 Institut Georges Lopez Latest Developments
11.11 Ebers
  11.11.1 Ebers Company Information
  11.11.2 Ebers Ex Vivo Organ Perfusion Product Offered
  11.11.3 Ebers Ex Vivo Organ Perfusion Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Ebers Main Business Overview
  11.11.5 Ebers Latest Developments
11.12 Penn Medicine
  11.12.1 Penn Medicine Company Information
  11.12.2 Penn Medicine Ex Vivo Organ Perfusion Product Offered
  11.12.3 Penn Medicine Ex Vivo Organ Perfusion Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 Penn Medicine Main Business Overview
  11.12.5 Penn Medicine Latest Developments
11.13 Johns Hopkins Medicine
  11.13.1 Johns Hopkins Medicine Company Information
  11.13.2 Johns Hopkins Medicine Ex Vivo Organ Perfusion Product Offered
  11.13.3 Johns Hopkins Medicine Ex Vivo Organ Perfusion Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 Johns Hopkins Medicine Main Business Overview
  11.13.5 Johns Hopkins Medicine Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Ex Vivo Organ Perfusion Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Ex Vivo Organ Perfusion Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Heart Perfusion
Table 4. Major Players of Liver Perfusion
Table 5. Major Players of Kidney Perfusion
Table 6. Major Players of Lung Perfusion
Table 7. Ex Vivo Organ Perfusion Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Ex Vivo Organ Perfusion Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Ex Vivo Organ Perfusion Market Size Market Share by Type (2021-2026)
Table 10. Ex Vivo Organ Perfusion Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Ex Vivo Organ Perfusion Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Ex Vivo Organ Perfusion Market Size Market Share by Application (2021-2026)
Table 13. Global Ex Vivo Organ Perfusion Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Ex Vivo Organ Perfusion Revenue Market Share by Player (2021-2026)
Table 15. Ex Vivo Organ Perfusion Key Players Head office and Products Offered
Table 16. Ex Vivo Organ Perfusion Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Ex Vivo Organ Perfusion Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Ex Vivo Organ Perfusion Market Size Market Share by Region (2021-2026)
Table 21. Global Ex Vivo Organ Perfusion Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Ex Vivo Organ Perfusion Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Ex Vivo Organ Perfusion Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Ex Vivo Organ Perfusion Market Size Market Share by Country (2021-2026)
Table 25. Americas Ex Vivo Organ Perfusion Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Ex Vivo Organ Perfusion Market Size Market Share by Type (2021-2026)
Table 27. Americas Ex Vivo Organ Perfusion Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Ex Vivo Organ Perfusion Market Size Market Share by Application (2021-2026)
Table 29. APAC Ex Vivo Organ Perfusion Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Ex Vivo Organ Perfusion Market Size Market Share by Region (2021-2026)
Table 31. APAC Ex Vivo Organ Perfusion Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Ex Vivo Organ Perfusion Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Ex Vivo Organ Perfusion Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Ex Vivo Organ Perfusion Market Size Market Share by Country (2021-2026)
Table 35. Europe Ex Vivo Organ Perfusion Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Ex Vivo Organ Perfusion Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Ex Vivo Organ Perfusion Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Ex Vivo Organ Perfusion Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Ex Vivo Organ Perfusion Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Ex Vivo Organ Perfusion
Table 41. Key Market Challenges & Risks of Ex Vivo Organ Perfusion
Table 42. Key Industry Trends of Ex Vivo Organ Perfusion
Table 43. Global Ex Vivo Organ Perfusion Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Ex Vivo Organ Perfusion Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Ex Vivo Organ Perfusion Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Ex Vivo Organ Perfusion Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. TransMedics Details, Company Type, Ex Vivo Organ Perfusion Area Served and Its Competitors
Table 48. TransMedics Ex Vivo Organ Perfusion Product Offered
Table 49. TransMedics Ex Vivo Organ Perfusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. TransMedics Main Business
Table 51. TransMedics Latest Developments
Table 52. Lung Bioengineering Details, Company Type, Ex Vivo Organ Perfusion Area Served and Its Competitors
Table 53. Lung Bioengineering Ex Vivo Organ Perfusion Product Offered
Table 54. Lung Bioengineering Ex Vivo Organ Perfusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Lung Bioengineering Main Business
Table 56. Lung Bioengineering Latest Developments
Table 57. OrganOx Details, Company Type, Ex Vivo Organ Perfusion Area Served and Its Competitors
Table 58. OrganOx Ex Vivo Organ Perfusion Product Offered
Table 59. OrganOx Ex Vivo Organ Perfusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. OrganOx Main Business
Table 61. OrganOx Latest Developments
Table 62. XVIVO Details, Company Type, Ex Vivo Organ Perfusion Area Served and Its Competitors
Table 63. XVIVO Ex Vivo Organ Perfusion Product Offered
Table 64. XVIVO Ex Vivo Organ Perfusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. XVIVO Main Business
Table 66. XVIVO Latest Developments
Table 67. TNO Details, Company Type, Ex Vivo Organ Perfusion Area Served and Its Competitors
Table 68. TNO Ex Vivo Organ Perfusion Product Offered
Table 69. TNO Ex Vivo Organ Perfusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. TNO Main Business
Table 71. TNO Latest Developments
Table 72. UHN Details, Company Type, Ex Vivo Organ Perfusion Area Served and Its Competitors
Table 73. UHN Ex Vivo Organ Perfusion Product Offered
Table 74. UHN Ex Vivo Organ Perfusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. UHN Main Business
Table 76. UHN Latest Developments
Table 77. SCREEN Details, Company Type, Ex Vivo Organ Perfusion Area Served and Its Competitors
Table 78. SCREEN Ex Vivo Organ Perfusion Product Offered
Table 79. SCREEN Ex Vivo Organ Perfusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. SCREEN Main Business
Table 81. SCREEN Latest Developments
Table 82. Bridge to Life Details, Company Type, Ex Vivo Organ Perfusion Area Served and Its Competitors
Table 83. Bridge to Life Ex Vivo Organ Perfusion Product Offered
Table 84. Bridge to Life Ex Vivo Organ Perfusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Bridge to Life Main Business
Table 86. Bridge to Life Latest Developments
Table 87. Organ Recovery Systems Details, Company Type, Ex Vivo Organ Perfusion Area Served and Its Competitors
Table 88. Organ Recovery Systems Ex Vivo Organ Perfusion Product Offered
Table 89. Organ Recovery Systems Ex Vivo Organ Perfusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Organ Recovery Systems Main Business
Table 91. Organ Recovery Systems Latest Developments
Table 92. Institut Georges Lopez Details, Company Type, Ex Vivo Organ Perfusion Area Served and Its Competitors
Table 93. Institut Georges Lopez Ex Vivo Organ Perfusion Product Offered
Table 94. Institut Georges Lopez Ex Vivo Organ Perfusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Institut Georges Lopez Main Business
Table 96. Institut Georges Lopez Latest Developments
Table 97. Ebers Details, Company Type, Ex Vivo Organ Perfusion Area Served and Its Competitors
Table 98. Ebers Ex Vivo Organ Perfusion Product Offered
Table 99. Ebers Ex Vivo Organ Perfusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Ebers Main Business
Table 101. Ebers Latest Developments
Table 102. Penn Medicine Details, Company Type, Ex Vivo Organ Perfusion Area Served and Its Competitors
Table 103. Penn Medicine Ex Vivo Organ Perfusion Product Offered
Table 104. Penn Medicine Ex Vivo Organ Perfusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Penn Medicine Main Business
Table 106. Penn Medicine Latest Developments
Table 107. Johns Hopkins Medicine Details, Company Type, Ex Vivo Organ Perfusion Area Served and Its Competitors
Table 108. Johns Hopkins Medicine Ex Vivo Organ Perfusion Product Offered
Table 109. Johns Hopkins Medicine Ex Vivo Organ Perfusion Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Johns Hopkins Medicine Main Business
Table 111. Johns Hopkins Medicine Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Ex Vivo Organ Perfusion Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Ex Vivo Organ Perfusion Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Ex Vivo Organ Perfusion Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Ex Vivo Organ Perfusion Sales Market Share by Country/Region (2025)
Figure 8. Ex Vivo Organ Perfusion Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Ex Vivo Organ Perfusion Market Size Market Share by Type in 2025
Figure 10. Ex Vivo Organ Perfusion in Organ Transplant Specialist Hospitals
Figure 11. Global Ex Vivo Organ Perfusion Market: Organ Transplant Specialist Hospitals (2021-2026) & ($ millions)
Figure 12. Ex Vivo Organ Perfusion in Organ Banks
Figure 13. Global Ex Vivo Organ Perfusion Market: Organ Banks (2021-2026) & ($ millions)
Figure 14. Ex Vivo Organ Perfusion in Pharmaceutical Research Organizations
Figure 15. Global Ex Vivo Organ Perfusion Market: Pharmaceutical Research Organizations (2021-2026) & ($ millions)
Figure 16. Global Ex Vivo Organ Perfusion Market Size Market Share by Application in 2025
Figure 17. Global Ex Vivo Organ Perfusion Revenue Market Share by Player in 2025
Figure 18. Global Ex Vivo Organ Perfusion Market Size Market Share by Region (2021-2026)
Figure 19. Americas Ex Vivo Organ Perfusion Market Size 2021-2026 ($ millions)
Figure 20. APAC Ex Vivo Organ Perfusion Market Size 2021-2026 ($ millions)
Figure 21. Europe Ex Vivo Organ Perfusion Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Ex Vivo Organ Perfusion Market Size 2021-2026 ($ millions)
Figure 23. Americas Ex Vivo Organ Perfusion Value Market Share by Country in 2025
Figure 24. United States Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Ex Vivo Organ Perfusion Market Size Market Share by Region in 2025
Figure 29. APAC Ex Vivo Organ Perfusion Market Size Market Share by Type (2021-2026)
Figure 30. APAC Ex Vivo Organ Perfusion Market Size Market Share by Application (2021-2026)
Figure 31. China Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 35. India Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Ex Vivo Organ Perfusion Market Size Market Share by Country in 2025
Figure 38. Europe Ex Vivo Organ Perfusion Market Size Market Share by Type (2021-2026)
Figure 39. Europe Ex Vivo Organ Perfusion Market Size Market Share by Application (2021-2026)
Figure 40. Germany Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 41. France Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Ex Vivo Organ Perfusion Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Ex Vivo Organ Perfusion Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Ex Vivo Organ Perfusion Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Ex Vivo Organ Perfusion Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 54. APAC Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 55. Europe Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 57. United States Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 58. Canada Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 59. Mexico Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 60. Brazil Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 61. China Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 62. Japan Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 63. Korea Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 65. India Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 66. Australia Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 67. Germany Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 68. France Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 69. UK Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 70. Italy Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 71. Russia Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 72. Egypt Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 73. South Africa Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 74. Israel Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 75. Turkey Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)
Figure 76. Global Ex Vivo Organ Perfusion Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Ex Vivo Organ Perfusion Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Ex Vivo Organ Perfusion Market Size 2027-2032 ($ millions)